Bioceres Crop Solutions vs CVR Partners, LP
BIOX and UAN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIOX and UAN compare
CVR Partners, LP grew revenue faster over the last twelve months (17.5% versus −17.7% for Bioceres Crop Solutions).
CVR Partners, LP pays a dividend yielding 9.3%; Bioceres Crop Solutions does not pay one.
CVR Partners, LP scores higher on the StockData Score (15 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIOX | UAN |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.2B |
| Share price | $0.233 | $112.92 |
| Change, 1 year | −86.6% | 16.2% |
| Change, 5 years | −98.5% | 37.3% |
| Beta (5Y) | 0.76 | 0.51 |
| Employees | 562 | 320 |
| StockData Score | ||
| Total score | 1 | 15 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 7.4× |
| P/S | – | 1.8× |
| EV/EBITDA | – | 5.9× |
| P/FCF | – | 8.3× |
| FCF yield | – | 12.1% |
| Fair value | – | $244.74 |
| Margin of safety | – | 53.9% |
| Growth | ||
| Revenue growth (TTM) | −17.7% | 17.5% (better) |
| Revenue growth, 5Y average | 2.6% | 11.6% (better) |
| Net income growth (TTM) | – | 82.2% |
| EPS growth (TTM) | – | 82.2% |
| Profitability | ||
| Gross margin | 34.9% (better) | 33.5% |
| Operating margin | −9.8% | 28.1% (better) |
| Net margin | – | 23.7% |
| FCF margin | 27.3% (better) | 21.4% |
| Return on invested capital | −7.4% | – |
| Financial health | ||
| Debt / equity | 10.01 | – |
| Net debt / EBITDA | – | 1.57 |
| Interest coverage | −0.6× | – |
| Current ratio | 0.80 | 3.01 (better) |
| Piotroski F-score | – | 8 |
| Dividends and buybacks | ||
| Dividend yield | – | 9.3% |
| Shareholder yield | – | 9.3% |
| Ownership | ||
| Held by institutions | 13.2% | 53.6% |
| Held by insiders | 73.3% | 78.2% |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.7% | 8.6% |
Go deeper
- BIOX stock overview
- BIOX income statement
- BIOX valuation and score
- UAN stock overview
- UAN income statement
- UAN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.